Every aspect of science and research is based on data, and across the globe, labs are producing more data than the average person can even comprehe...
Since 2019, Cytiva has committed over $1.6 billion to expand its global manufacturing capacity. In this exclusive conversation with BioPharma BoardRoom, Pi...
ADCs are no longer a niche modality. To date, there are over a dozen approved ADCs on the market, and more than 500 programs are in clinical development, d...
In this exclusive interview with BioPharma BoardRoom, Jessay Devassy, Manager, Bioprocess Applications at Ecolab Bioprocessing&...
Novo Nordisk’s announcement of an executive reshuffle marks more than a routine leadership transition. It signals a strat...
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31...
In this exclusive interview with BioPharma BoardRoom, Mike Kadan, PhD, MBA, Chief Operating Officer of Vector BioMed, shares how the company is reimagining...
The Trump administration has launched a bold and controversial national security investigation into America’s heavy reliance on impor...
Matt Boag, Biopharmaceutical Product Marketing Manager at Phenomenex, discusses the transformative innovations shaping plasmid DNA, mRNA, and peptide purif...
In a thought-provoking Q&A with BioPharma BoardRoom, Demaris Mills, President of Integrated DNA Technologies (IDT), discusses the transformative advanc...
In a detailed interview with BioPharma BoardRoom, Kerstin Pohl, Senior Global Marketing Manager for Gene Therapy & Nucleic Acid at SCIEX, delves into t...
As the biopharma industry continues to evolve, sustainability has emerged as a key driver of progress. Ryan Walker, Sustainability Program Leader at Cyt...
As we step into 2025, the biopharmaceutical industry is poised at the intersection of unprecedented innovation and transformative growth. With each yea...
As 2025 unfolds, the pharmaceutical, biopharmaceutical, and biotechnology industries are on the brink of a transformative shift. With mergers and a...
© 2025 Biopharma Boardroom. All Rights Reserved.
